Client Services > Labs
Our start-to-finish solution for clinical trials begins with understanding our client’s end goals for the study and aiding them in the study design. Throughout the project we remain in on-going contact with our sponsors to ensure that the project is managed with the best interest of the client in mind.
At the end of each study, our clinical study team develops a final report package that includes the test protocol, study data, applicable statistical analysis and a summary report. Each final report package is reviewed by our quality assurance department and senior scientific staff prior to sending it to the client.
All testing is conducted on healthy human subjects and takes place in one of two clinical trials laboratory locations. In all cases, prior to recruitment of subjects, clinical studies require the approval of the Gallatin Institutional Review Board (GIRB), a group of individuals not employed by BSLI, but with whom BSLI contracts to review study protocols withe the specific objective of ensuring subject safety. Also, in addition to the hands-on medical services provided by two consulting physicians who are not GIRB members, the GRIB ensures that unexpected and/or untoward physical reactions of any kind experienced by subjects during the course of a clinical study, termed Adverse Events (AEs), are addressed, treated, and resolved appropriately.